Drug Trial Radar · NCT05001347
A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors
Last checked: Nov 19, 2026Latest source record: Dec 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Nov 2, 2021
Primary completion
Feb 8, 2023
Study completion Feb 8, 2023
Sponsor
- Lead sponsor
- I-Mab Biopharma US LimitedIndustry
- Sponsor type
- Industry
- First posted
- Aug 11, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, open label, Phase 2 study of TJ004309 in combination with atezolizumab in patients with advanced or metastatic solid tumors.
Conditions
- Ovarian Cancer
- Head and Neck Cancer
- Non Small Cell Lung Cancer
- Gastrointestinal Cancer
- Triple Negative Breast Cancer
- Ovarian Carcinoma
Interventions
TJ004309Drug
Antibody to CD73
Primary outcomes
What the sponsor says the trial is designed to measure.
- To Assess the Efficacy of TJ004309 Combined With Atezolizumab in a Cohort of Patients With Platinum-resistant IO Naive Ovarian Carcinoma and a Separate Biomarker Enriched Cohort of Subjects With Selected Tumor TypesTime frame: Up to 66 weeks
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Arizona Oncology Associates
Tucson, Arizona
Innovative Clinical Research Institute
Whittier, California
Medical Oncology Hematology Consultants, PA
Newark, Delaware
Illinois Cancer Specialists
Arlington Heights, Illinois
Women's Cancer Care
Covington, Louisiana
Maryland Oncology Hematology
Rockville, Maryland
Laura and Isaac Perlmutter Cancer Center at NYU Langone
New York, New York
Duke Cancer Center
Durham, North Carolina
Tri County Hematology and Oncology Associates
Massillon, Ohio
Texas Oncology - Arlington North
Arlington, Texas
Texas Oncology - Austin Central
Austin, Texas
Texas Oncology - Forth Worth Cancer Center
Fort Worth, Texas
Texas Oncology - The Woodlands, Gynecologic Oncology
The Woodlands, Texas
Virginia Cancer Specialists
Fairfax, Virginia
Northwest Cancer Specialists
Vancouver, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.